Fiasp 100 U/ml Solution for injection
PDF Leaflet Revision Date: 09 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Maintenance treatment of diabetes mellitus.
Dosage (summary)
Individualized; typically 0.5-1.0 unit/kg/day.
Onset of Action / Duration
Onset: 16-20 mins, Duration: 3-5 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; insulin does not cross placenta.
Key Drug Interactions
- Oral antidiabetics
- Beta-blockers
- Thiazides
- Glucocorticoids
Contraindications
- Hypersensitivity to insulin aspart
- Hypoglycaemia
Common side effects
- Hypoglycaemia
- Allergic skin reactions
- Lipodystrophy
Counselling Points
- Monitor blood glucose regularly
- Rotate injection sites
- Carry glucose for hypoglycaemia
Serious warnings
- Risk of severe hypoglycaemia
- Not established for ketoacidosis
Important Disclaimer
The Fiasp 100 U/ml Solution for injection professional information leaflet below is the property of Novo Nordisk and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
